APP and metabolic dysfunction-associated steatotic liver disease: Mice with NAFLD had a significant 20% lower brain perfusion (p < 0.05) than control mice (Figure 6A), in contrast to unchanged perfusion observed when comparing APP/PS1 mice with WT fed with a standard diet (Figure S1).